Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The treatment was not recommended due to limited effectiveness and significant side effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Dutasteride mesotherapy can cause hair loss in some people.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Breast cancer patients undergoing chemotherapy often worry, lose weight, and cope by praying, meditating, or seeking support.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Dutasteride injections can help treat hair loss in men and women.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.